{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:17:46Z","timestamp":1771039066774,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>With the increase in maternal antidepressant prescribing before\/during pregnancy, concerns about the safety of antidepressants have come into focus. The purpose of this study was to explore the association between maternal antidepressant use before pregnancy\/in early pregnancy and the risk of congenital heart disease (CHD) in children, and to provide a scientific basis for clinical safety of antidepressant use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The prospective cohort study ultimately included 34,104 singleton pregnancies. Modified Poisson regression model with robust error variances was used to evaluate RRs and 95% confidence intervals (CIs) for the risk of CHD in offspring exposed to maternal antidepressant in the 3 months before pregnancy and early pregnancy. In addition, sensitivity analysis was further performed to explore the robustness of the results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this study, the maternal antidepressant exposure rate was 2.83% in the 3 months before pregnancy, 2.42% in early pregnancy, and the incidence of CHD was 8.973 per 1,000 live births. We found that maternal antidepressant use in the 3 months before pregnancy and early pregnancy were all associated with an increased risk of CHD, ~2.54 times and 2.87 times, respectively, of non-use of antidepressants after adjusting for potential confounders. This association was also found in CHD specific phenotypic analysis. Of these, offspring whose mothers were exposed to antidepressants in the 3 months before pregnancy had the highest risk of transposition of the great arteries (aOR = 5.50, 95% CI: 1.91\u201315.88). The offspring of mothers exposed to antidepressants in early pregnancy had the highest risk of developing ventricular septal defect (aOR = 4.80, 95% CI: 2.50\u20139.24). Sensitivity analysis verified the stability of the results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Maternal antidepressant use in the 3 months before pregnancy and early pregnancy were all associated with an increased risk of CHD in their offspring. In order to reduce the risk of teratogenesis, we recommend that pregnant women prepare for pregnancy after their condition improves or receive the minimum effective dose of medication.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.916882","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:02:11Z","timestamp":1656997331000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of Maternal Antidepressant Use During the Pre-pregnancy\/Early Pregnancy Period on Congenital Heart Disease: A Prospective Cohort Study in Central China"],"prefix":"10.3389","volume":"9","author":[{"given":"Mengting","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senmao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinli","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.psychres.2013.09.027","article-title":"Gender differences in depression and anxiety: the role of age","volume":"210","author":"Faravelli","year":"2013","journal-title":"Psychiatry Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jad.2020.07.046","article-title":"Prevalence of perinatal depression and its determinants in Mainland China: a systematic review and meta-analysis","volume":"277","author":"Nisar","year":"2020","journal-title":"J Affect Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/pds.3661","article-title":"First-trimester exposure to bupropion and risk of cardiac malformations","volume":"23","author":"Louik","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.JAA.0000460911.55472.76","article-title":"Are antidepressants safe in the first trimester of pregnancy?","volume":"28","author":"Shealy","year":"2015","journal-title":"JAAPA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ije\/dyz009","article-title":"Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies","volume":"48","author":"Liu","year":"2019","journal-title":"Int J Epidemiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jpeds.2018.08.040","article-title":"Prevalence of congenital heart disease at live birth in China","volume":"204","author":"Zhao","year":"2019","journal-title":"J Pediatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1161\/CIRCULATIONAHA.115.019881","article-title":"Brain in congenital heart disease across the lifespan: the cumulative burden of injury","volume":"133","author":"Marelli","year":"2016","journal-title":"Circulation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIR.0b013e318265ee8a","article-title":"Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association","volume":"126","author":"Marino","year":"2012","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tins.2018.12.003","article-title":"Cortical dysmaturation in congenital heart disease","volume":"42","author":"Leonetti","year":"2019","journal-title":"Trends Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3389\/fphys.2018.01045","article-title":"The role of abnormal placentation in congenital heart disease; cause, correlate, or consequence?","volume":"9","author":"Courtney","year":"2018","journal-title":"Front Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/biom9120879","article-title":"Genetics of congenital heart disease","volume":"9","author":"Williams","year":"2019","journal-title":"Biomolecules."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e001978","DOI":"10.1161\/CIRCGEN.117.001978","article-title":"A screening approach to identify clinically actionable variants causing congenital heart disease in exome data","volume":"11","author":"Szot","year":"2018","journal-title":"Circ Genom Precis Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1503\/cmaj.051421","article-title":"Paroxetine (Paxil) and congenital malformations","volume":"173","author":"Williams","year":"2005","journal-title":"CMAJ."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/pds.1463","article-title":"Paroxetine in the first trimester and the prevalence of congenital malformations","volume":"16","author":"Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/bdra.20641","article-title":"First-trimester use of paroxetine and congenital heart defects: a population-based case-control study","volume":"88","author":"Bakker","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"h3190","DOI":"10.1136\/bmj.h3190","article-title":"Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports","volume":"351","author":"Reefhuis","year":"2015","journal-title":"BMJ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2020.2453","article-title":"Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects","volume":"77","author":"Anderson","year":"2020","journal-title":"JAMA Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/bcp.13161","article-title":"Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies","volume":"83","author":"Shen","year":"2017","journal-title":"Br J Clin Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40264-020-01027-x","article-title":"A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants","volume":"44","author":"De","year":"2021","journal-title":"Drug Saf."},{"key":"B20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.295.5.499","article-title":"Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment","volume":"295","author":"Cohen","year":"2006","journal-title":"JAMA."},{"key":"B21","doi-asserted-by":"publisher","first-page":"106963","DOI":"10.1016\/j.ypmed.2022.106963","article-title":"Effect of maternal alcohol consumption during the pre-pregnancy\/early-pregnancy period on congenital heart disease: a prospective cohort study in Central China","volume":"155","author":"Wang","year":"2022","journal-title":"Prev Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/EDE.0b013e318225c2be","article-title":"DAGitty: a graphical tool for analyzing causal diagrams","volume":"22","author":"Textor","year":"2011","journal-title":"Epidemiology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/1471-0528.16772","article-title":"Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study","volume":"128","author":"Kolding","year":"2021","journal-title":"BJOG."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N Engl J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/cga.12386","article-title":"Association between antidepressant use during pregnancy and congenital anomalies in children: a retrospective cohort study based on Japanese claims data","volume":"60","author":"Yamamoto-Sasaki","year":"2020","journal-title":"Congenit Anom (Kyoto)."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1248\/yakushi.130.1381","article-title":"Survey on the attitudes of pregnant and lactating women about the use of drugs","volume":"130","author":"Takagi","year":"2010","journal-title":"Yakugaku Zasshi."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.jelectrocard.2007.05.021","article-title":"Impact of ancillary subunits on ventricular repolarization","volume":"40","author":"Abbott","year":"2007","journal-title":"J Electrocardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/cvr\/cvs296","article-title":"Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism","volume":"97","author":"Danielsson","year":"2013","journal-title":"Cardiovasc Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pharmthera.2017.05.001","article-title":"Drug-induced fatal arrhythmias: acquired long QT and Brugada syndromes","volume":"176","author":"Turker","year":"2017","journal-title":"Pharmacol Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cpcardiol.2018.04.002","article-title":"Long QT syndrome: a comprehensive review of the literature and current evidence","volume":"44","author":"Shah","year":"2019","journal-title":"Curr Probl Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"b3569","DOI":"10.1136\/bmj.b3569","article-title":"Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study","volume":"339","author":"Pedersen","year":"2009","journal-title":"BMJ."},{"key":"B33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.reprotox.2005.11.006","article-title":"Antidepressant drugs during pregnancy and infant congenital heart defect","volume":"21","author":"Kallen","year":"2006","journal-title":"Reprod Toxicol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s004410100408","article-title":"Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis","volume":"305","author":"Buznikov","year":"2001","journal-title":"Cell Tissue Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1242\/dev.124.9.1745","article-title":"5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells","volume":"124","author":"Choi","year":"1997","journal-title":"Development."},{"key":"B36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/dbio.2001.0409","article-title":"The outflow tract of the heart is recruited from a novel heart-forming field","volume":"238","author":"Mjaatvedt","year":"2001","journal-title":"Dev Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.cellbio.23.090506.123331","article-title":"Heart field: from mesoderm to heart tube","volume":"23","author":"Abu-Issa","year":"2007","journal-title":"Annu Rev Cell Dev Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.reprotox.2011.09.004","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and heart defects: potential mechanisms for the observed associations","volume":"32","author":"Sadler","year":"2011","journal-title":"Reprod Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"Sanchez","year":"1999","journal-title":"Cell Mol Neurobiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.916882\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:02:13Z","timestamp":1656997333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.916882\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":39,"alternative-id":["10.3389\/fcvm.2022.916882"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.916882","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"article-number":"916882"}}